Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: Rationale and design of a pilot cluster randomised trial

BMC Family Practice

Volumn 10, Issue , 2009, Pages

  Siriwardena, A Niroshan ^a,b   Apekey, Tanefa ^b   Tilling, Michelle ^b   Harrison, Andrew ^c   Dyas, Jane V ^d   Middleton, Hugh C ^e   Ørner, Roderick ^f   Sach, Tracey ^g   Dewey, Michael ^h   Qureshi, Zubair M ^b  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c Church Lane   (United Kingdom)

^d The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f Somerby Clinic   (United Kingdom)

^g UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; EDUCATION; GENERAL PRACTICE; HUMAN; INSOMNIA; METHODOLOGY; NURSING EDUCATION; PILOT STUDY; PRIMARY HEALTH CARE; PROBLEM BASED LEARNING; RANDOMIZED CONTROLLED TRIAL;

COST-BENEFIT ANALYSIS; EDUCATION, NURSING; FAMILY PRACTICE; HUMANS; PILOT PROJECTS; PRIMARY HEALTH CARE; PROBLEM-BASED LEARNING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 62549165128     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-10-9     Document Type: Article

References (37)

1. Epidemiology of insomnia: a longitudinal study in a UK population. H Morphy KM Dunn M Lewis HF Boardman PR Croft, Sleep 2007 30 3 274 280 17425223
2. An international survey of sleeping problems in the general population. D Leger B Poursain D Neubauer M Uchiyama, Curr Med Res Opin 2008 24 1 307 317 10.1185/030079907X253771 18070379
3. Help-seeking for insomnia among adult patients in primary care. JE Aikens ME Rouse, J Am Board Fam Pract 2005 18 4 257 261 10.3122/jabfm.18.4.257 15994471
4. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. SA Martin JE Aikens RD Chervin, Sleep Med Rev 2004 8 1 63 72 10.1016/j.smrv.2003.08.001 15062211
5. GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. AN Siriwardena Z Qureshi S Gibson S Collier M Latham, Br J Gen Pract 2006 56 533 964 967 17132386
6. General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing. AN Siriwardena R Ørner T Apekey M Tilling J Dyas H Middleton, J Eval Clin Pract 2009
7. Benzodiazepines and hip fractures in elderly people: case-control study. C Pierfitte G Macouillard M Thicoipe A Chaslerie F Pehourcq M Aissou, BMJ 2001 322 7288 704 708 11264208 10.1136/bmj.322.7288.704
8. Greater incidence of depression with hypnotic use than with placebo. DF Kripke, BMC Psychiatry 2007 7 42 17711589 10.1186/1471-244X-7-42
9. Medical illness, medication use and suicide in seniors: a population-based case control study. DC Voaklander BH Rowe DM Dryden J Pahal P Saar KD Kelly, J Epidemiol Community Health 2008 62 2 138 146 10.1136/jech.2006.055533 18192602
10. Chronic hypnotic use: deadly risks, doubtful benefit. DF Kripke, Sleep Med Rev 2000 4 1 5 20 10.1053/smrv.1999.0076 12531158
11. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. J Glass KL Lanctot N Herrmann BA Sproule UE Busto, BMJ 2005 331 7526 1169 16284208 10.1136/bmj.38623.768588.47
12. The socioeconomic impact of insomnia. An overview. LA Chilcott CM Shapiro, Pharmacoeconomics 1996 10 Suppl 1 1 14 10163422
13. The economic cost of sleep disorders. DR Hillman AS Murphy L Pezzullo, Sleep 2006 29 3 299 305 16553015
14. Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. AN Siriwardena MZ Qureshi JV Dyas H Middleton R Orner, Br J Gen Pract 2008 58 551 417 422 10.3399/bjgp08X299290 18505619
15. Experiences of insomnia for patients and prescribers in the primary care consultation - a focus group study. J Dyas T Apekey M Tilling H Middleton J Sharp RJ Ørner, Society for Academic Primary Care Annual Scientific Meeting, Galway 2008
16. Developing a psychosocial intervention for sleep problems presenting to primary care (REST: Resources for Effective Sleep Treatment). AN Siriwardena T Apekey M Tilling RJ Ørner MZ Qureshi J Dyas, The future of primary care Southampton University 2008
17. A primary care "friendly" cognitive behavioral insomnia therapy. JD Edinger WS Sampson, Sleep 2003 26 2 177 182 12683477
18. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. T Morgenthaler M Kramer C Alessi L Friedman B Boehlecke T Brown, Sleep 2006 29 11 1415 1419 17162987
19. CONSORT statement: extension to cluster randomised trials. MK Campbell DR Elbourne DG Altman, BMJ 2004 328 7441 702 708 15031246 10.1136/bmj.328.7441.702
20. Internal and external validity of cluster randomised trials: systematic review of recent trials. S Eldridge D Ashby C Bennett M Wakelin G Feder, BMJ 2008 336 7649 876 880 18364360 10.1136/bmj.39517.495764.25
21. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. DJ Buysse CF Reynolds TH Monk SR Berman DJ Kupfer, Psychiatry Res 1989 28 193 213 10.1016/0165-1781(89)90047-4 2748771
22. Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care. AN Siriwardena A Rashid MRD Johnson ME Dewey, Br J Gen Pract 2002 52 482 735 740 12236277
23. Measuring outcomes in randomized clinical trials of insomnia treatments. CM Morin, Sleep Med Rev 2003 7 3 263 279 10.1053/smrv.2002.0274 12927124
24. Reliability and factor analysis of the Epworth Sleepiness Scale. MW Johns, Sleep 1992 15 4 376 381 1519015
25. An inventory for measuring depression. AT Beck CH Ward M Mendelson J Mock J Erbaugh, Arch Gen Psychiatry 1961 4 561 571 13688369
26. EuroQol: the current state of play. R Brooks, Health Policy 1996 37 1 53 72 10.1016/0168-8510(96)00822-6 10158943
27. What does an idiographic measure (PSYCHLOPS) tell us about the spectrum of psychological issues and scores on a nomothetic measure (CORE-OM)? M Ashworth S Robinson C Evans M Shepherd A Connolly G Rowlands, Primary Care and Community Psychiatry 2007 12 1 7 16
28. MF Drummond, Methods for the economic evaluation of health care programmes Oxford: Oxford University Press 2005
29. H Glick, Economic evaluation in clinical trials Oxford: Oxford University Press 2007
30. UK Working Party on Patient Costs (2001). S Thompson S Wordsworth, An annotated cost questionnaire for completion by patients 2001
31. Office of Health Economics. (London E: Productivity costs principles and practice in economic evaluation. C Pritchard MJ Sculpher, London: Office of Health Economics 2000
32. Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives. MV Pauly S Nicholson D Polsky ML Berger C Sharda, Health Econ 2008 17 4 469 485 10.1002/hec.1266 17628862
33. Unit costs of health and social care. L Curtis A Netten, Personal Social Services Research Unit 2007 http://www.pssru.ac.uk
34. Methods for analyzing cost effectiveness data from cluster randomized trials. MO Bachmann L Fairall A Clark M Mugford, Cost Eff Resour Alloc 2007 5 12 17822546 10.1186/1478-7547-5-12
35. Representing uncertainty: the role of cost-effectiveness acceptability curves. E Fenwick K Claxton M Sculpher, Health Econ 2001 10 8 779 787 10.1002/hec.635 11747057
36. Framework for design and evaluation of complex interventions to improve health. M Campbell R Fitzpatrick A Haines AL Kinmonth P Sandercock D Spiegelhalter, BMJ 2000 321 7262 694 696 10987780 10.1136/bmj.321.7262.694
37. Developing and evaluating complex interventions: the new Medical Research Council guidance. P Craig P Dieppe S Macintyre S Michie I Nazareth M Petticrew, BMJ 2008 337 a1655 10.1136/bmj.a1655 18824488